236 related articles for article (PubMed ID: 10930892)
21. Efficacy of a multistep strategy for Helicobacter pylori eradication.
Gasbarrini A; Ojetti V; Armuzzi A; Branca G; Canducci F; Torre ES; Candelli M; Pastorelli A; Anti M; Fedeli G; Fadda G; Pola P; Gasbarrini G
Aliment Pharmacol Ther; 2000 Jan; 14(1):79-83. PubMed ID: 10632649
[TBL] [Abstract][Full Text] [Related]
22. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Gisbert JP; Marcos S; Gisbert JL; Pajares JM
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
[TBL] [Abstract][Full Text] [Related]
24. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.
Uygun A; Kadayifci A; Yesilova Z; Ates Y; Safali M; Ilgan S; Bagci S; Dagalp K
Indian J Gastroenterol; 2007; 26(4):174-7. PubMed ID: 17986746
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
26. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Perri F; Villani MR; Quitadamo M; Annese V; Niro GA; Andriulli A
Aliment Pharmacol Ther; 2001 Jul; 15(7):1017-22. PubMed ID: 11421877
[TBL] [Abstract][Full Text] [Related]
27. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
28. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
[TBL] [Abstract][Full Text] [Related]
29. Ranitidine bismuth citrate.
Chiba N; Hunt RH; Thomson AB
Can J Gastroenterol; 2001 Jun; 15(6):389-98. PubMed ID: 11429668
[TBL] [Abstract][Full Text] [Related]
30. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Vakil N; Cutler A
Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
[TBL] [Abstract][Full Text] [Related]
32. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
Bardhan KD; Dallaire C; Eisold H; Duggan AE
Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
[TBL] [Abstract][Full Text] [Related]
33. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Calvet X; Montserrat A; Güell M; Vergara M; Gené E
Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):987-90. PubMed ID: 15371921
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
[TBL] [Abstract][Full Text] [Related]
37. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
38. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
39. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Gisbert JP; Pajares JM
Aliment Pharmacol Ther; 2002 Jun; 16(6):1047-57. PubMed ID: 12030945
[TBL] [Abstract][Full Text] [Related]
40. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]